Clinical Trials Browser

Interventional × Has results × Arthritis, Rheumatoid × Clear all

Arthritis, Rheumatoid, Autoimmune Diseases, Osteoarthritis, Psoriasis

NCT03649061 2025-06-19

CareRA2020

Phase 4 Completed

276 enrolled 20 charts

Arthritis, Rheumatoid

NCT02760433 2023-09-21

CREDO 3

Phase 3 Completed

368 enrolled 21 charts

Arthritis, Rheumatoid

NCT03449758 2022-04-28

SariPRO

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Phase 2 Completed

617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

NCT00837434 2021-09-22

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

Phase 4 Completed

63 enrolled 26 charts

Arthritis, Rheumatoid

NCT01960855 2021-08-24

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Phase 2 Completed

276 enrolled 14 charts

Arthritis, Arthritis, Rheumatoid, Joint Diseases, Musculoskeletal Diseases

NCT02092467 2021-08-17

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Phase 4 Completed

4,372 enrolled 22 charts

Arthritis, Rheumatoid

NCT01548768 2020-11-27

RHYTHM

Phase 4 Completed

149 enrolled 15 charts

Arthritis, Rheumatoid, Cardiovascular Diseases

NCT03001219 2020-01-29

A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Phase 2 Terminated

109 enrolled 24 charts

Arthritis, Rheumatoid

NCT01721044 2019-09-18

RA-BEACON

Phase 3 Completed

527 enrolled 37 charts

Arthritis, Rheumatoid

NCT00960440 2018-12-19

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Phase 3 Completed

399 enrolled 51 charts

Arthritis, Rheumatoid

NCT02046603 2018-12-07

ACT-MOVE

Phase 3 Completed

162 enrolled 30 charts

Arthritis, Rheumatoid

NCT02862574 2018-06-27

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Phase 2 Terminated

15 enrolled 11 charts

Arthritis, Rheumatoid

NCT00503425 2017-08-15

A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Phase 3 Completed

215 enrolled 9 charts

Arthritis, Rheumatoid

NCT01351480 2017-03-13

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

Phase 3 Completed

34 enrolled 8 charts

Arthritis, Arthritis, Rheumatoid

NCT00357903 2017-02-09

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

Phase 3 Completed

639 enrolled 27 charts

Arthritis, Rheumatoid

NCT01715896 2016-10-31

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

Phase 2 Completed

215 enrolled 37 charts

Arthritis, Rheumatoid

NCT00468546 2016-10-25

A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Phase 3 Completed

520 enrolled 17 charts

Arthritis, Rheumatoid

NCT02519387 2016-07-20

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Phase 4 Completed

78 enrolled 9 charts

Arthritis, Rheumatoid, Osteoarthritis, Low Back Pain, Arthralgia, Myalgia

NCT01350804 2016-05-23

NURTURE 1

Phase 3 Completed

551 enrolled 19 charts

Arthritis, Rheumatoid

NCT00651625 2016-03-02

RPD

Phase NA Completed

437 enrolled 8 charts

Head & Neck

Arthritis, Rheumatoid, Neoplasms, Osteoarthritis, Pain, Wounds and Injuries, Thyroid Nodule

NCT00883753 2014-08-06

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

Phase 3 Completed

934 enrolled 40 charts

Arthritis, Rheumatoid

NCT00361335 2014-07-29

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Phase 3 Completed

643 enrolled 14 charts

Arthritis, Rheumatoid

NCT01374971 2014-04-08

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

Phase 3 Completed

12 enrolled 4 charts

Arthritis, Rheumatoid

NCT01283971 2014-02-10

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Phase 4 Terminated

96 enrolled 27 charts

Arthritis, Rheumatoid

NCT00427804 2013-02-04

Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption

Phase NA Completed

9 enrolled 6 charts

Arthritis, Rheumatoid, Crohn Disease

NCT00048581 2011-11-21

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Phase 3 Completed

738 enrolled 84 charts

Arthritis, Rheumatoid

Clinical Trials

VITAL

CareRA2020

CREDO 3

SariPRO

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

RHYTHM

A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

RA-BEACON

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

ACT-MOVE

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

A Study of MabThera (Rituximab) in Participants With Rheumatoid Arthritis Who Have Had an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARD) and/or Anti-Tumor Necrosis Factor (Anti-TNF) Therapy.

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

NURTURE 1

RPD

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.